Results 11 to 20 of about 3,631,478 (254)

Glial Fibrillary Acidic Protein as a Biomarker in Acute Ischemic Stroke: Diagnostic Value and Prognostic Implications

open access: yesNamık Kemal Tıp Dergisi
Stroke is one of the leading causes of mortality and long-term disability worldwide, with ischemic stroke representing the most common subtype. Despite significant progress in neuroimaging and reperfusion therapies, rapid and accurate diagnosis remains a
Ümit ATASEVER
doaj   +2 more sources

Serum glial fibrillary acidic protein and protein gene product 9.5 for predicting neurological outcomes in cardiac arrest patients with cortical response to somatosensory evoked potentials

open access: yesResuscitation Plus
Aim: Predicting neurological prognosis after cardiac arrest remains challenging. Somatosensory evoked potential N20 absence is highly specific but lacks sensitivity.
Chenchen Hang   +8 more
doaj   +2 more sources

Glial Fibrillary Acidic Protein-Expressing Glia in the Mouse Lung

open access: yesASN Neuro, 2015
Autonomic nerves regulate important functions in visceral organs, including the lung. The postganglionic portion of these nerves is ensheathed by glial cells known as non-myelinating Schwann cells.
Gabriela B. Suarez-Mier   +1 more
doaj   +2 more sources

Prospective Validation of Glial Fibrillary Acidic Protein, d‐Dimer, and Clinical Scales for Acute Large‐Vessel Occlusion Ischemic Stroke Detection

open access: yesStroke: Vascular and Interventional Neurology
Background Large‐vessel occlusion (LVO) ischemic stroke is responsible for significant morbidity and mortality. We have previously described a novel tool for acute LVO detection that combines blood‐based biomarkers (glial fibrillary acidic protein and d ...
Yasir Durrani   +21 more
doaj   +2 more sources

Prognostic Value of Neurofilament Light Chain and Glial Fibrillary Acidic Protein in ALD-Related Myelopathy. [PDF]

open access: yesAnn Clin Transl Neurol
ABSTRACT Background X‐linked adrenoleukodystrophy (X‐ALD) is a neurometabolic disorder caused by pathogenic variants in ABCD1, leading to slowly progressive spinal cord disease in nearly all affected men. Sensitive biomarkers to quantify disease severity and predict progression are needed for clinical care and trial design.
Kabak EG   +4 more
europepmc   +2 more sources

Evaluation of Dried Plasma Spot-Based Quantification of Glial Fibrillary Acidic Protein as a Disease-Associated Biomarker in Neuromyelitis Optica Spectrum Disorder. [PDF]

open access: yesAnn Clin Transl Neurol
ABSTRACT Objective To evaluate the diagnostic accuracy of glial fibrillary acidic protein (GFAP) measured in dried plasma spots versus conventional plasma‐ and serum‐GFAP testing for assessment of disease severity in aquaporin‐4 immunoglobulin G–positive neuromyelitis optica spectrum disorder (AQP4‐IgG+ NMOSD).
Wohlrab F   +19 more
europepmc   +2 more sources

Research progress of autoimmune glial fibrillary acidic protein astrocytopathy

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2022
Autoimmune glial fibrillary acidic protein astrocytopathy (GFAP ⁃ A) is a novel autoimmune inflammatory disease of the central nervous system first reported in 2016.
WANG Wen⁃wen, LI Mei
doaj   +1 more source

Diagnostic values of glial fibrillary acidic protein, neuron-specific enolase and protein S100β for sepsis-associated encephalopathy

open access: yesRomanian Journal of Laboratory Medicine, 2023
To investigate the expressions of glial fibrillary acidic protein (GFAP), neuron-specific enolase (NSE) and protein S100β and their diagnostic values for sepsis-associated encephalopathy (SAE).
Cao Zhigang, Huang Xiang, Chen Feixiang
doaj   +1 more source

Proteomic profiling of the brain from the wobbler mouse model of amyotrophic lateral sclerosis reveals elevated levels of the astrogliosis marker glial fibrillary acidic protein

open access: yesEuropean Journal of Translational Myology, 2023
The wobbler mouse is a widely used model system of amyotrophic lateral sclerosis and exhibits progressive neurodegeneration and neuroinflammation in association with skeletal muscle wasting.
Sandra Murphy   +6 more
doaj   +1 more source

Blood levels of Glial Fibrillary Acidic Protein (GFAP) in patients with neurological diseases [PDF]

open access: yes, 2013
Background and Purpose: The brain-specific astroglial protein GFAP is a blood biomarker candidate indicative of intracerebral hemorrhage in patients with symptoms suspicious of acute stroke.
Niessner, Marion   +11 more
core   +2 more sources

Home - About - Disclaimer - Privacy